INIS · Radnostix Inc
Market Cap
$31.75M
Shares
529.15M
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Revenue
$13.07M
-6%
FY2025
Net Income
-$908K
-10690.2%
FY2025
Gross Margin
58.93%
-3.3pp
FY2025
Operating Margin
-7.32%
-7.4pp
FY2025
Diluted EPS
$0.00
FY2025
Operating Cash Flow
$620.16K
-2.9%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $11.23M | $13.07M | $13.9M | $12.27M | $11.18M | $9.66M | $9.36M | $8.96M | $10.37M | $7.42M | — | — | — | — | — | — | — | |
| $5.19M | $5.37M | $5.25M | $4.89M | $4.89M | $3.92M | $3.9M | $4.29M | $5.68M | $4.18M | — | — | — | — | — | — | — | |
| $6.04M | $7.7M | $8.65M | $7.38M | $6.29M | $5.74M | $5.46M | $4.67M | $4.69M | $3.24M | $2.84M | $2.7M | $2.98M | $2.54M | $2.65M | $3.42M | $2.49M | |
| — | 58.93% | 62.22% | 60.15% | 56.25% | 59.39% | 58.3% | 52.1% | 45.23% | 43.63% | — | — | — | — | — | — | — | |
| $490.38K | $435.84K | $610.74K | $577.35K | $533.72K | $271.71K | $219.5K | $263.38K | $468.6K | $376.7K | $511.28K | $821.45K | $464.21K | $706.05K | $990.02K | $1.7M | $5.23M | |
| $3.69M | $3.73M | $4.01M | $3.55M | $3.57M | $3.46M | $2.83M | $2.4M | $2.2M | $2.81M | $2.05M | $1.65M | $1.61M | $2.13M | $1.95M | $2.03M | $1.74M | |
| — | $164.9K | $164.9K | $164.9K | $164.37K | $163.18K | $166.5K | $166.7K | $165.28K | $132.39K | $112.72K | $107.49K | $113.36K | $131.07K | $100.77K | $23.41K | — | |
| $420.73K | $402.44K | $401.07K | $350.09K | $374.2K | $581.27K | $300.12K | $268.03K | $267.72K | $241.44K | $226.86K | $211.17K | $263.52K | $415.61K | $415.18K | $392.99K | $453.14K | |
| $8.94M | $8.66M | $8.64M | $8.16M | $7.49M | $6.42M | $5.88M | $5.22M | $4.98M | $5.3M | $4.35M | $4.14M | $3.76M | $4.63M | $4.84M | $6.79M | $8.82M | |
| -$2.9M | -$956.19K | $6901 | -$776.3K | -$1.2M | -$680.79K | -$415.67K | -$558.3K | -$290.06K | -$2.07M | -$1.5M | -$1.44M | -$785.88K | -$2.1M | -$2.18M | -$3.37M | -$6.33M | |
| — | -7.32% | 0.05% | -6.33% | -10.76% | -7.05% | -4.44% | -6.23% | -2.8% | -27.84% | — | — | — | — | — | — | — | |
| -$2.48M | -$553.75K | $407.97K | -$426.21K | -$828.7K | -$99.52K | -$115.55K | -$290.26K | -$22.35K | -$1.82M | -$1.28M | -$1.23M | -$522.37K | -$1.68M | -$1.77M | -$2.98M | -$5.88M | |
| $341.5K | $339.28K | $328.68K | $331.78K | $613.94K | $791.53K | $781.84K | $541.27K | $470.11K | $509.74K | $474.06K | $497.99K | $936.53K | $469.04K | $203.6K | $2.81M | $496.78K | |
| $64.82K | $76.63K | $122.39K | $78.89K | $9502 | $111 | $3192 | $13.09K | $9428 | $3051 | $938 | $438 | $586 | $1147 | $502 | $4724 | $3449 | |
| $36.01K | $48.19K | $1673 | -$92.72K | $1.51M | -$108.17K | $2.86M | -$642.69K | -$373.88K | -$1.66M | -$392.56K | -$384.32K | -$753.35K | — | — | — | — | |
| $0 | — | — | — | — | — | — | — | — | $53.17K | $73.96K | $89.28K | $96.06K | -$57.65K | -$54.46K | -$141.64K | $0 | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | -$837.03K | -$761.88K | -$2.02M | — | |
| -$2.86M | -$908K | $8574 | -$869.02K | $303.24K | -$902.35K | $2.2M | -$1.52M | -$844.58K | -$3.76M | -$1.88M | -$1.82M | -$1.55M | -$2.46M | -$2.24M | -$5.95M | -$6.8M | |
| — | -6.95% | 0.06% | -7.08% | 2.71% | -9.34% | 23.52% | -17.01% | -8.15% | -50.63% | — | — | — | — | — | — | — | |
| — | — | — | — | — | $113.39K | $240.06K | $321.97K | $180.63K | $34.96K | -$16.43K | -$7755 | $5846 | -$23.72K | -$41.29K | -$76.48K | — | |
| -$1.91M | — | — | — | — | — | — | — | — | — | — | -$1.82M | -$1.55M | — | — | — | — | |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | — | — | — | — | — | — | — | — | — | — |
| USD/shares | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.01 | — | — | — | — | — | — | — | — | — | — |
| shares | — | 526.8M | 522.29M | 517.78M | 510.79M | 477.72M | 423.09M | 418.08M | 411.07M | 406.36M | 403.3M | 398.06M | 369.33M | 365.2M | 359.89M | 334.65M | 299.87M |
| shares | — | 526.8M | 522.29M | 517.78M | 510.79M | 477.72M | 431.21M | 418.08M | 411.07M | 406.36M | 403.3M | 398.06M | 369.33M | 365.2M | 359.89M | 334.65M | 299.87M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
EV/Revenue
2.85×
Peer median 0.88×
EV/EBIT
—
Peer median 8.91×
P/E (TTM)
—
Peer medians compare against the 41 similar-size Drug Manufacturers - Specialty & Generic companies (of 98 listed).
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Theranostics Products | $6,841,094 | $8,006,315 | $6,842,898 | $6,045,767 | — | — |
| Calibration Reference Products | $4,248,074 | $3,519,216 | — | — | — | — |
| Cobalt Products | $1,752,217 | $2,365,572 | $1,037,073 | $1,157,536 | $1,354,517 | $1,225,580 |
| Medical Device Products | $228,951 | $8,657 | $0 | — | — | — |
| Fluorine Products | $0 | $0 | $0 | $0 | $29,775 | $178,350 |
| Nuclear Medicine Products | — | $3,519,216 | $4,387,414 | $3,978,685 | $4,002,606 | $3,673,256 |
| Radiochemical Products | — | — | — | $6,045,767 | $4,275,044 | $4,071,571 |
| Radiological Services | — | — | — | — | $160,159 | $216,139 |
By Geography (USD)
| Component | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|
| United States | $10,023,667 | $9,648,831 | $8,198,872 | $8,084,762 |
| Non Us | $2,243,718 | $1,533,157 | $1,463,070 | $1,280,134 |